Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: a systematic literature review.

Author: HendriksA G M, KeijsersR R M C, SeygerM M B, de JongE M G J, van de KerkhofP C M

Paper Details 
Original Abstract of the Article :
Most psoriasis patients suffering from mild to moderate disease are treated with first-line topical treatments, including corticosteroids, vitamin D analogues, topical retinoids and calcineurin inhibitors. Although evidence-based guidelines on combinations are lacking, the majority of patients will ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/jdv.12058

データ提供:米国国立医学図書館(NLM)

Combining Topical Treatments for Psoriasis: A Systematic Review

Psoriasis, a chronic skin condition, affects millions of people worldwide. This study explores the use of combinations of first-line topical treatments for chronic plaque psoriasis.

Finding the Right Combination for Psoriasis

The researchers reviewed existing literature on the efficacy and safety of combining topical treatments, such as corticosteroids, vitamin D analogues, topical retinoids, and calcineurin inhibitors.

A Tailored Approach to Psoriasis Management

This review highlights the importance of finding the right combination of treatments for each individual with psoriasis. Just as a camel adapts to different desert conditions, people with psoriasis may require different combinations of treatments to achieve the best possible results.

Dr.Camel's Conclusion

This systematic review underscores the need for evidence-based guidelines on the use of topical treatment combinations for psoriasis. It also emphasizes the importance of individualized treatment plans to optimize patient outcomes.
Date :
  1. Date Completed 2014-02-04
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

23279069

DOI: Digital Object Identifier

10.1111/jdv.12058

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.